文献速递心力衰竭与心肌病冠心病血脂与心血管预防

慢性肾脏病中心力衰竭、冠心病和卒中的绝对发生率:3项社区队列研究分析

Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies.
PubMed 文献 · JAMA Cardiol · 2017-01-01

该研究汇总3项社区队列中无心血管病基线者,比较合并与不合并慢性肾脏病(CKD)者新发心力衰竭、冠心病和卒中的绝对发生率和风险差,发现CKD与心力衰竭风险升高相关,幅度与冠心病相近且大于卒中,在非洲裔和西班牙裔中尤为明显。

要点

  • CKD患者心力衰竭、冠心病和卒中的未调整发生率均高于无CKD者。
  • 多因素调整后,CKD与心力衰竭和冠心病风险差相近,卒中风险差较小。
  • 非洲裔和西班牙裔CKD患者的心力衰竭超额风险尤其大。

核心结论

  • 在3项多样化社区队列中,CKD与心力衰竭风险升高相关,幅度与冠心病相近且大于卒中。
  • CKD相关的心力衰竭超额风险在非洲裔和西班牙裔个体中尤其大。
  • 改善CKD患者健康结局的努力应优先关注心力衰竭以及冠心病预防。

研究设计与样本

  • 汇总3项社区队列研究(Jackson心脏研究、心血管健康研究、多民族动脉粥样硬化研究)中无基线心血管病的参与者。
  • Jackson心脏研究于2000年至2010年开展,心血管健康研究于1989年至2003年开展,多民族动脉粥样硬化研究于2000年至2012年开展。
  • CKD定义为基于肌酐-胱抑素C联合CKD-EPI方程计算的估算肾小球滤过率低于60 mL/min/1.73 m2。
  • 共纳入14462名参与者,平均(标准差)年龄63(12)岁,女性59%(n=8533),非洲裔美国人44%(n=6363)。
  • 1461名(10%)患有CKD,平均(标准差)估算肾小球滤过率为49(10)mL/min/1.73 m2。

主要发现

  • 合并与不合并CKD者心力衰竭未调整发生率分别为每1000人年22.0(95%CI 19.3-24.8)和6.2(95%CI 5.8-6.7)。
  • 合并与不合并CKD者冠心病未调整发生率分别为每1000人年24.5(95%CI 21.6-27.5)和8.4(95%CI 7.9-9.0)。
  • 合并与不合并CKD者卒中未调整发生率分别为每1000人年13.4(95%CI 11.3-15.5)和4.8(95%CI 4.4-5.3)。
  • 调整人口学、队列、高血压、糖尿病、高脂血症和吸烟后,合并与不合并CKD者心力衰竭风险差为每1000人年2.3(95%CI 1.2-3.3)。
  • 调整后合并与不合并CKD者冠心病风险差为每1000人年2.3(95%CI 1.2-3.4),卒中风险差为每1000人年0.8(95%CI 0.09-1.5)。

关键数值与推荐

  • 在非洲裔和西班牙裔参与者中,调整后合并与不合并CKD者心力衰竭风险差分别为每1000人年3.5(95%CI 1.5-5.5)和7.8(95%CI 2.2-13.3)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cardiovascular disease is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). Understanding the relative contributions of cardiovascular disease event types to the excess burden of cardiovascular disease is important for developing effective strategies to improve outcomes. OBJECTIVE: To determine absolute rates and risk differences of incident heart failure (HF), coronary heart disease (CHD), and stroke in participants with vs without CKD. DESIGN, SETTING AND PARTICIPANTS: We pooled participants without prevalent cardiovascular disease from 3 community-based cohort studies: the Jackson Heart Study, Cardiovascular Health Study, and Multi-Ethnic Study of Atherosclerosis. The Jackson Heart Study was conducted between 2000 and 2010, the Cardiovascular Health Study was conducted between 1989 and 2003, and the Multi-Ethnic Study of Atherosclerosis was conducted between 2000 and 2012. EXPOSURES: Chronic kidney disease was defined as estimated glomerular filtration rate less than 60 mL/min/1.73 m2, calculated using the combined creatinine-cystatin C CKD-Epidemiology Collaboration Equation. MAIN OUTCOMES AND MEASURES: Poisson regression was used to calculate incidence rates (IRs) and risk differences of adjudicated incident HF, CHD, and stroke, comparing participants with vs without CKD. RESULTS: Among 14 462 participants, the mean (SD) age was 63 (12) years, 59% (n = 8533) were women, and 44% (n = 6363) were African American. Overall, 1461 (10%) had CKD (mean [SD] estimated glomerular filtration rate, 49 [10] mL/min/1.73 m2). Unadjusted IRs for participants with and without CKD, respectively, were 22.0 (95% CI, 19.3-24.8) and 6.2 (95% CI, 5.8-6.7) per 1000 person-years for HF; 24.5 (95% CI, 21.6-27.5) and 8.4 (95% CI, 7.9-9.0) per 1000 person-years for CHD; and 13.4 (95% CI, 11.3-15.5) and 4.8 (95% CI, 4.4-5.3) for stroke. Adjusting for demographics, cohort, hypertension, diabetes, hyperlipidemia, and tobacco use, risk differences comparing participants with vs without CKD (per 1000 person-years) were 2.3 (95% CI, 1.2-3.3) for HF, 2.3 (95% CI, 1.2-3.4) for CHD, and 0.8 (95% CI, 0.09-1.5) for stroke. Among African American and Hispanic participants, adjusted risk differences comparing participants with vs without CKD for HF were 3.5 (95% CI, 1.5-5.5) and 7.8 (95% CI, 2.2-13.3) per 1000 person-years, respectively. CONCLUSIONS AND RELEVANCE: Among 3 diverse community-based cohorts, CKD was associated with an increased risk of HF that was similar in magnitude to CHD and greater than stroke. The excess risk of HF associated with CKD was particularly large among African American and Hispanic individuals. Efforts to improve health outcomes for patients with CKD should prioritize HF in addition to CHD prevention.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Bansal N, Katz R, Robinson-Cohen C, et al. Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies. JAMA Cardiol. 2017. PMID: 28002548. doi:10.1001/jamacardio.2016.4652

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。